Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Müller

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
New Drug for Chronic Myeloid Leukemia Might Stimulate the MarketMartin C Müller
Blood|August 31, 2013
The ne plus ultra for deep BCR-ABL sequencing?Martin C Müller
Annals of Hematology|March 28, 2015
Response-related predictors of survival in CMLBenjamin Hanfstein, Martin C Müller, Andreas Hochhaus
Current Cancer Drug Targets|November 11, 2010
Current treatment concepts of CMLArmin A Leitner, Andreas Hochhaus, Martin C Müller
Leukemia Research|September 9, 2011
Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patientGee Fung How, Martin C Müller, Lay Cheng Lim
Annals of Hematology|March 28, 2015
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardizationNicholas C P Cross, Andreas Hochhaus, Martin C Müller
Hematology/Oncology Clinics of North America|November 8, 2011
BCR-ABL mutations in chronic myeloid leukemiaThomas Ernst, Paul La Rosée, Martin C Müller, et al.
Clinical Chemistry and Laboratory Medicine|February 29, 2008
Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemiaThomas Ernst, Jana Hoffmann, Philipp Erben, et al.
Annals of Hematology|December 4, 2014
A multi-state model approach for prediction in chronic myeloid leukaemiaMichael Lauseker, Joerg Hasford, Verena S Hoffmann, et al.
Plos One|August 13, 2015
Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assayWiltrud Haaß, Helga Kleiner, Martin C Müller, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
New Drug for Chronic Myeloid Leukemia Might Stimulate the MarketMartin C Müller
Blood|August 31, 2013
The ne plus ultra for deep BCR-ABL sequencing?Martin C Müller
Annals of Hematology|March 28, 2015
Response-related predictors of survival in CMLBenjamin Hanfstein, Martin C Müller, Andreas Hochhaus
Current Cancer Drug Targets|November 11, 2010
Current treatment concepts of CMLArmin A Leitner, Andreas Hochhaus, Martin C Müller
Leukemia Research|September 9, 2011
Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patientGee Fung How, Martin C Müller, Lay Cheng Lim
Annals of Hematology|March 28, 2015
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardizationNicholas C P Cross, Andreas Hochhaus, Martin C Müller
Hematology/Oncology Clinics of North America|November 8, 2011
BCR-ABL mutations in chronic myeloid leukemiaThomas Ernst, Paul La Rosée, Martin C Müller, et al.
Clinical Chemistry and Laboratory Medicine|February 29, 2008
Suitability of the PAXgene system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemiaThomas Ernst, Jana Hoffmann, Philipp Erben, et al.
Annals of Hematology|December 4, 2014
A multi-state model approach for prediction in chronic myeloid leukaemiaMichael Lauseker, Joerg Hasford, Verena S Hoffmann, et al.
Plos One|August 13, 2015
Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assayWiltrud Haaß, Helga Kleiner, Martin C Müller, et al.
Pageof 8